MENTAL RETARDATION, AUTOSOMAL RECESSIVE 42
|
0.600 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Loss of function of PGAP1 as a cause of severe encephalopathy identified by Whole Exome Sequencing: Lessons of the bioinformatics pipeline.
|
26050939 |
2015 |
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 42
|
0.600 |
GeneticVariation
|
disease |
CLINVAR |
PGAP1 knock-out mice show otocephaly and male infertility.
|
17711852 |
2007 |
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 42
|
0.600 |
CausalMutation
|
disease |
CLINVAR |
|
|
|
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 42
|
0.600 |
Biomarker
|
disease |
CTD_human |
|
|
|
Autosomal recessive spastic paraplegia type 67
|
0.300 |
GermlineCausalMutation
|
disease |
ORPHANET |
Exome sequencing links corticospinal motor neuron disease to common neurodegenerative disorders.
|
24482476 |
2014 |
Holoprosencephaly
|
0.200 |
Biomarker
|
disease |
MGD |
|
|
|
Central visual impairment
|
0.120 |
Biomarker
|
disease |
BEFREE |
After classification, variants in four genes known to be associated with CVI (AHDC1, NGLY1, NR2F1, PGAP1) in 5 patients (20%) were identified, establishing a conclusive genetic diagnosis for CVI.
|
26350515 |
2016 |
Intellectual Disability
|
0.120 |
GeneticVariation
|
group |
BEFREE |
In conclusion, we report novel PGAP1 variants in a boy with CVI and ID and a proven functional loss of PGAP1 and show, to our knowledge, for the first time this genetic association with CVI.
|
25804403 |
2015 |
Central visual impairment
|
0.120 |
GeneticVariation
|
disease |
BEFREE |
In conclusion, we report novel PGAP1 variants in a boy with CVI and ID and a proven functional loss of PGAP1 and show, to our knowledge, for the first time this genetic association with CVI.
|
25804403 |
2015 |
Intellectual Disability
|
0.120 |
GeneticVariation
|
group |
BEFREE |
Null mutation in PGAP1 impairing Gpi-anchor maturation in patients with intellectual disability and encephalopathy.
|
24784135 |
2014 |
Intellectual Disability
|
0.120 |
Biomarker
|
group |
HPO |
|
|
|
Central visual impairment
|
0.120 |
Biomarker
|
disease |
HPO |
|
|
|
Cerebral atrophy
|
0.110 |
GeneticVariation
|
disease |
BEFREE |
Other that the common symptoms related to PGAP1 mutations including non-progressive psychomotor retardation, neonatal feeding problems, microcephaly and brain atrophy these patients displayed severely delayed myelination and recurrent apneas thereby widing the clinical spectrum associated with such mutations.
|
27206732 |
2016 |
Muscle Spasticity
|
0.110 |
GeneticVariation
|
phenotype |
BEFREE |
Homozygous variants in PGAP1 (post-GPI attachment to proteins 1) have recently been identified in two families with developmental delay, seizures and/or spasticity.
|
25804403 |
2015 |
Global developmental delay
|
0.110 |
GeneticVariation
|
disease |
BEFREE |
Homozygous variants in PGAP1 (post-GPI attachment to proteins 1) have recently been identified in two families with developmental delay, seizures and/or spasticity.
|
25804403 |
2015 |
Muscle Spasticity
|
0.110 |
Biomarker
|
phenotype |
HPO |
|
|
|
Cerebral atrophy
|
0.110 |
Biomarker
|
disease |
HPO |
|
|
|
Global developmental delay
|
0.110 |
Biomarker
|
disease |
HPO |
|
|
|
Chorea
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Depressive disorder
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Dwarfism
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Dyskinetic syndrome
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Dystonia
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Impulsive Behavior
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Macrostomia
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|